In the last trading session, 0.23 million Q32 Bio Inc (NASDAQ:QTTB) shares changed hands as the company’s beta touched -0.37. With the company’s per share price at $3.31 changed hands at $0.08 or 2.48% during last session, the market valuation stood at $40.07M. QTTB’s last price was a discount, traded about -1525.08% off its 52-week high of $53.79. The share price had its 52-week low at $3.02, which suggests the last value was 8.76% up since then. When we look at Q32 Bio Inc’s average trading volume, we note the 10-day average is 1.27 million shares, with the 3-month average coming to 280.59K.
Analysts gave the Q32 Bio Inc (QTTB) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.80. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended QTTB as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Q32 Bio Inc’s EPS for the current quarter is expected to be 0.
Q32 Bio Inc (NASDAQ:QTTB) trade information
Instantly QTTB was in green as seen at the end of in last trading. With action -4.08%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -69.94%, with the 5-day performance at -4.08% in the red. However, in the 30-day time frame, Q32 Bio Inc (NASDAQ:QTTB) is -86.60% down. Looking at the short shares, we see there were 0.72 million shares sold at short interest cover period of 6.74 days.
The consensus price target for the stock as assigned by Wall Street analysts is 80, meaning bulls need an upside of 95.86% from its current market value. According to analyst projections, QTTB’s forecast low is 64 with 95 as the target high. To hit the forecast high, the stock’s price needs a -2770.09% plunge from its current level, while the stock would need to soar -1833.53% for it to hit the projected low.
Q32 Bio Inc (QTTB) estimates and forecasts
Data shows that the Q32 Bio Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -78.77% over the past 6 months, a 83.20% in annual growth rate that is considerably higher than the industry average of 16.70%.
The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -0.07%. The 2024 estimates are for Q32 Bio Inc earnings to increase by 25.44%, but the outlook for the next 5-year period is at -9.40% per year.
QTTB Dividends
Q32 Bio Inc is expected to release its next quarterly earnings report in January.
